Imagine a tiny electronic 'tripwire' made of a single layer of carbon that can spot a virus the moment it touches it. Instead of sending samples to a lab and waiting days, this device works like a digital lock and key to identify whole viruses instantly. It's designed to be a portable alarm system for farms and clinics to stop outbreaks before they spread.
Current viral diagnostics are too slow and rely on centralized labs, making them useless for real-time pandemic prevention at the animal-human interface.
A label-free biosensing platform using miniGFET arrays and a database of 700 virus-human receptor pairs for target selection.
If you are a smart farm provider dealing with the risk of zoonotic diseases in animal husbandry — this project developed an automated sensor that enables continuous in-situ monitoring. This allows for the detection of viral threats before they jump to humans, reducing potential economic losses from pandemics.
If you are a diagnostic company dealing with long turnaround times in centralized labs — this project developed a label-free gFET platform that detects intact viral particles in real-time. This provides a portable, automated alternative for emergency medicine and critical care settings.
If you are a health agency dealing with the need for rapid pandemic preparedness — this project developed a modular sensing system that can be quickly adapted to new pathogens. This shortens the time from identifying a new virus to deploying a functional diagnostic test.
Based on available project data, specific pricing or production costs are not provided.
The project has transitioned from single sensors to miniGFET arrays to improve stability and reproducibility, which is a step toward scaling, though full industrial capacity is not detailed.
Based on available project data, there is no specific information regarding patents or licensing agreements.
The system uses pressure-controlled microfluidics and is designed for automated, continuous monitoring in animal farms.
The project period runs from 2024-03-01 to 2027-08-31, suggesting the technology is currently in the development and testing phase.
The consortium is heavily research-oriented, consisting of 7 partners across 4 countries. With 5 research organizations and 1 university, the academic weight is high, while industrial presence is low at 14% (1 SME). This suggests the project is currently focused on technical validation rather than immediate commercial rollout.
Contact the Universidade da Coruña in Spain
Contact us to find licensing opportunities for gFET biosensing technology.
